Medtronic seeks US approval for drug-coated stents
10th Oct 2005, 17:33 GMT
Medtronic has taken the 1st step in the US approval process for its Endeavor drug-coated coronary stents.
Medtronic seeks US approval for drug-coated stents related news:
- Drug-Coated Stents Better for Diabetics (HealthDay) — Yahoo! Health: Heart Health News
- Drug-Coated Stents Better for Diabetics — MedicineNet Cholesterol General
- Medtronic Starts Endeavor FDA Submission — Angiography/ Cardiac Cath News from StratCenter.com
- Medtronic Submits 1st PMA Module to the US FDA for Endeavor Drug-Eluting Coronary Stent — Radiology News from StratCenter.com
- Ranbaxy Says It's Won Drug Approval — StratWire - Business of Healthcare NewsFeed
- North Shore-LIJ receives FDA approval for new drug application to manufacture PET scan drug — EurekAlert! - Business and Economics
- Jury Awards Medtronic $51 mln in Patent Case — Physician News News from StratCenter.com
- Pfizer Cancer Drug Gets Wider Approval — Operations-Related News from StratCenter.com
- Medtronic Annual Institutional Investor/Analyst Update, 10/11/2005 — StratWire - Business of Healthcare NewsFeed
- Jury awards Medtronic $51M in patent case — Latest news from The Minneapolis/St. Paul Business Journal
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease